SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-18-000012
Filing Date
2018-08-09
Accepted
2018-08-09 17:17:21
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10q_2018q2.htm 10-Q 1216313
2 EXHIBIT 31.1 alpn-ex311_20180630.htm EX-31.1 11829
3 EXHIBIT 31.2 alpn-ex312_20180630.htm EX-31.2 11748
4 EXHIBIT 32.1 alpn-ex321_20180630.htm EX-32.1 6578
5 EXHIBIT 32.2 alpn-ex322_20180630.htm EX-32.2 6651
  Complete submission text file 0001626199-18-000012.txt   4579793

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alpn-20180630.xml EX-101.INS 714724
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20180630.xsd EX-101.SCH 38244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20180630_cal.xml EX-101.CAL 59038
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20180630_def.xml EX-101.DEF 183601
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20180630_lab.xml EX-101.LAB 467549
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20180630_pre.xml EX-101.PRE 287622
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 181006355
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences